BRAF and melanoma: Melanoma cell intrinsic resistance to BRAF inhibitors seems to be diverse and independent resistance mechanisms may even develop in parallel in different tumour lesions (Chan et al., 2014; Menzies et al., 2014; Wilmott et al., 2012).